Status: Recruiting
Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
The objective of the study is to evaluate an ultraportable ultrasound device, Hepatoscope, for the non-invasive assessment of hepatic steatosis in patients with metabolic-dysfunction associated liver diseases (MASLD), by comparing its measurements with current diagnostic modalities, such as MRI-PDFF.
Participants needed: 120
Trial details
Age: 18-80Biological sex: AllType: InterventionalSponsor: E-ScopicsUpdated: Aug 15, 2025Locations: 3
Eligibility criteria
Adult patient below 80 yo [+5]
Patient in their minority (less than 18 yo) or older than 80 yo, [+9]